Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00679185 · ClinicalTrials.gov registry record · NA
Expressive Writing in Improving Quality of Life in Patients With Breast Cancer and Lymphedema
A NA study, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 107
- Enrollment target
NCT00679185 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 107 participants.
The verdict
NCT00679185, a NA study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 107 participants
- Enrollment target
Study Summary
RATIONALE: Expressive writing may help relieve symptoms and improve quality of life in breast cancer survivors with chronic lymphedema. PURPOSE: This clinical trial is studying expressive writing in improving the quality of life in women with breast cancer and lymphedema.
Interventions
- BEHAVIORAL expressive writing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2007-01 |
| Est. Completion | 2011-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00679185
The ClinicalTrials.gov registry entry for NCT00679185 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which expressive writing is the first listed.
NCT00679185 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00679185 about?
NCT00679185 is a clinical study titled "Expressive Writing in Improving Quality of Life in Patients With Breast Cancer and Lymphedema". RATIONALE: Expressive writing may help relieve symptoms and improve quality of life in breast cancer survivors with chronic lymphedema. PURPOSE: This clinical trial is studying expressive writing in improving the quality of life in women with breast cancer and lymphedema.
What is the current status of trial NCT00679185?
This trial is currently completed. It is a NA study. The enrollment target is 107 participants. The study started on 2007-01. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00679185?
The interventions under investigation include: expressive writing (BEHAVIORAL).
Who is sponsoring clinical trial NCT00679185?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.